Indoco Remedies Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indoco Remedies Quarterly Results    (INDOCO)

Here are the latest quarterly results of Indoco Remedies. For more details, see the Indoco Remedies financial fact sheet and Indoco Remedies share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Indoco Remedies Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,3562,6262,5202,5272,9202,8932,7202,759 
Other income Rs m364966753 
Turnover Rs m2,3602,6312,5702,5332,9262,9012,7252,761 
Expenses Rs m2,2382,3782,2352,2992,5982,5422,3872,270 
Gross profit Rs m118248286228321351333489 
Depreciation Rs m177177195170180176182191 
Interest Rs m5037466154697858 
Profit before tax Rs m-105399439311378242 
Tax Rs m-27-14-22-1920202470 
Profit after tax Rs m-785311622739354172 
Gross profit margin %5.09.411.39.011.012.112.217.7 
Effective tax rate %26.0-36.9-23.7-678.621.317.530.928.9 
Net profit margin %-3.32.04.60.92.53.22.06.2 
Diluted EPS Rs -0.8 0.6 1.3 0.2 0.8 1.0 0.6 1.9  
Diluted EPS (TTM) Rs 2.5 0.7 -0.3 1.2 2.9 3.3 2.6 4.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Indoco Remedies 3QFY20 Result Performance Review

More Miscellaneous Company Quarterly Results:   SUVEN LIFESCIENCES  PROCTER & GAMBLE HEALTH  J.B.CHEMICALS  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare INDOCO REMEDIES With:   SUVEN LIFESCIENCES  PROCTER & GAMBLE HEALTH  J.B.CHEMICALS  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare INDOCO REMEDIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Jumped 505 Points Today(Closing)

Indian share markets continued momentum and ended their session on a strong note today.

Views on news

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Is this Sector the Best Contrarian Bet Right Now? (Profit Hunter)

Nov 23, 2020

The risk reward ratio in this beaten down sector may have finally turned for the better.

The Price of Dying, the Cost of Living (The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Dec 1, 2020 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS